Mark Russell

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial
  Circulation: Heart Failure 2025 DOI: 10.1161/CIRCHEARTFAILURE.124.012393
  +Save
• Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial
  Circulation: Heart Failure 2024 DOI: 10.1161/CIRCHEARTFAILURE.124.011663
  +Save
• Transforming Growth Factor-β Analysis of the VANISH Trial Cohort
  Circulation: Heart Failure 2023 DOI: 10.1161/CIRCHEARTFAILURE.122.010314
  +Save
• JAHA Spotlight on Pregnancy and Its Impact on Maternal and Offspring Cardiovascular Health
  Journal of the American Heart Association 2022 DOI: 10.1161/JAHA.121.025167
  +Save
• Molecular Management of Multifocal Atrial Tachycardia in Noonan’s Syndrome With MEK1/2 Inhibitor Trametinib
  Circulation: Genomic and Precision Medicine 2021 DOI: 10.1161/CIRCGEN.121.003327
  +Save
• Discordant clinical features of identical hypertrophic cardiomyopathy twins
  Proceedings of the National Academy of Sciences 2021 DOI: 10.1073/pnas.2021717118
  +Save